Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM) Meeting Abstract

  

Authors:	Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
Abstract Title:	Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
Meeting Title:	47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	29
Issue:	15 Suppl.
Meeting Dates:	2011 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2011-05-20
Language:	English
ACCESSION:	WOS:000208880304564
DOI:	10.1200/jco.2011.29.15_suppl.tps139
PROVIDER:	wos
Notes:	Meeting Abstract: TPS139 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/141472